Could an arsenic drink replace IV drips for leukemia patients?
Disease control
Completed
This study tested an oral liquid form of arsenic trioxide (SDK001) in 12 people with acute promyelocytic leukemia (APL). Researchers compared how well the body absorbs the oral drug versus the standard IV version, and whether food or calcium supplements change absorption. The goa…
Phase: PHASE1 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC